Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib
- Resource Type
- Review Article
- Source
- In
Critical Reviews in Oncology / Hematology February 2024 194 - Subject
MOL - Language
- ISSN
- 1040-8428